Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsumoto, K
Right arrow Articles by Takagi, K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsumoto, K
Right arrow Articles by Takagi, K

Chest, Vol 105, 681-686, Copyright © 1994 by American College of Chest Physicians


ARTICLES

Serum levels of soluble IL-2R, IL-4, and soluble Fc epsilon RII in adult bronchial asthma

K Matsumoto, F Taki, M Miura, M Matsuzaki and K Takagi
Second Department of Internal Medicine, Nagoya University School of Medicine, Japan.

Examination was made of the serum levels of interleukin 4 (IL-4), soluble Fc epsilon RII (sFc epsilon RII), and soluble interleukin 2 receptor (sIL-2R) in 77 adult patients with bronchial asthma. All the patients had mild to moderate asthma and their symptoms were well controlled. The results were compared with values for 75 control subjects to clarify the involvement of these factors in the pathogenesis of bronchial asthma. Serum sIL-2R was elevated in asthmatics compared with control subjects (459.0 +/- 30.4 U/ml vs 251.5 +/- 10.0 U/ml; p < 0.001). The IL-4 and sFc epsilon RII levels were also elevated beyond those in the controls (IL-4: 1.89 +/- 0.13 pg/ml vs 1.08 +/- 0.15 pg/ml; p < 0.001) (sFc epsilon RII: 313.2 +/- 18.8 U/ml vs 228.8 +/- 6.7 U/ml, p < 0.001). A weak but significant correlation was observed between sIL-2R and sFc epsilon RII (r = 0.46, p < 0.001). Correlation among other parameters was not found. The patients were divided into atopic and nonatopic groups, based on the presence or absence of positive reaction to skin prick tests using extracts of common aeroallergens and positive specific IgE against house dust mite (Dermatophagoides pteronyssinus [Dp]). Mean IL-4 in the atopic group, with positive skin reaction and > 0.7 kU/L specific IgE against Dp was significantly elevated compared with the nonatopic group (2.35 +/- 0.26 pg/ml vs 1.56 +/- 0.12 pg/ml; p < 0.005). Such differences could not be detected in sIL-2R, sFc epsilon RII levels among the two groups. No significant correlation could be found among IL-4, sFc epsilon RII, and total IgE level. The activation of T cells and B cells would thus appear essential to the pathogenesis of bronchial asthma and the hypothesis that atopic status is associated with the preferential activation of TH2 cells which selectively produce IL-4 could be supported. The regulatory mechanism of IgE synthesis would not appear to be the only responsible factor.


This article has been cited by other articles:


Home page
Eur Respir JHome page
M. Roponen, J. Kiviranta, M. Seuri, H. Tukiainen, R. Myllykangas-Luosujarvi, and M-R. Hirvonen
Inflammatory mediators in nasal lavage, induced sputum and serum of employees with rheumatic and respiratory disorders
Eur. Respir. J., September 1, 2001; 18(3): 542 - 548.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
A S. El-Radhi, C. L Hogg, J. K Bungre, A. Bush, and C. J Corrigan
Effect of oral glucocorticoid treatment on serum inflammatory markers in acute asthma
Arch. Dis. Child., August 1, 2000; 83(2): 158 - 162.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Zaitsu, Y. Hamasaki, M. Matsuo, A. Kukita, K. Tsuji, M. Miyazaki, R. Hayasaki, E. Muro, S. Yamamoto, I. Kobayashi, et al.
New induction of leukotriene A4 hydrolase by interleukin-4 and interleukin-13 in human polymorphonuclear leukocytes
Blood, July 15, 2000; 96(2): 601 - 609.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M.-P. ORYSZCZYN, I. ANNESI-MAESANO, D. CHARPIN, E. PATY, J. MACCARIO, and F. KAUFFMANN
Relationships of Active and Passive Smoking to Total IgE in Adults of the Epidemiological Study of the Genetics and Environment of Asthma, Bronchial Hyperresponsiveness, and Atopy (EGEA)
Am. J. Respir. Crit. Care Med., April 1, 2000; 161(4): 1241 - 1246.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. C. Bischoff, G. Sellge, A. Lorentz, W. Sebald, R. Raab, and M. P. Manns
IL-4 enhances proliferation and mediator release in mature human mast cells
PNAS, July 6, 1999; 96(14): 8080 - 8085.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
H.-Z. SHI, J.-M. DENG, H. XU, Z.-X. NONG, C.-Q. XIAO, Z.-M. LIU, S.-M. QIN, H.-X. JIANG, G.-N. LIU, and Y.-Q. CHEN
Effect of Inhaled Interleukin-4 on Airway Hyperreactivity in Asthmatics
Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 1818 - 1821.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American College of Chest Physicians.